Then, the downregulation of membrane-associated guanylate kinase, WW, and PDZ domain-containing protein 2 (MAGI2) occurs, leading to PTEN loss and the gefitinib resistance of lung cancer cells [246]. The gene discussed is PTEN; the disease is lung carcinoma.